로그인 회원가입
icon_bulk_order대량 주문 Acrobiosystems for English
0
장바구니가 비어 있습니다
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: > Akt1

Akt1

요약

Name:Serine/threonine-protein kinase AKT1
Target Synonym:EC:2.7.11.1,EC 2.7.11,Proto-oncogene c-Akt,Protein kinase B,RAC,RAC-PK-alpha,PKB alpha,RAC-alpha serine/threonine-protein kinase,AKT1,AKT Serine/Threonine Kinase 1,V-Akt Murine Thymoma Viral Oncogene Homolog 1,Protein Kinase B Alpha,PKB,V-Akt Murine Thymoma Viral Oncogene-Like Protein 1,Serine-Threonine Protein Kinase,Rac Protein Kinase Alpha,EC 2.7.11.1,PKB-ALPHA,RAC-ALPHA,AKT1m,PRKBA,CWS6,AKT
Number of Launched Drugs:1
Number of Drugs in Clinical Trials:19
Lastest Research Phase:Approved

제품 리스트 구매

제품 상태별:
제품 유형별 :
종별:
결합물별:
제품번호 제품 설명 구조 순도 특징
AK1-H5283 Human Human Akt1 Protein, His,Strep II Tag
AK1-H5283-structure
AK1-H5283-sds

Synonym Name

AKT1,PKB,RAC,RAC-PK-alpha,PKB alpha

Background

RAC-alpha serine/threonine-protein kinase (AKT1) is also known PKB, Protein kinase B alpha, PKB alpha, Proto-oncogene c-Akt and RAC-PK-alpha, which belongs to the protein kinase superfamily, AGC Ser/Thr protein kinase family and RAC subfamily and is expressed in prostate cancer and levels increase from the normal to the malignant state (at protein level). AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase).

Clinical and Translational Updates

임상 약품 정보

Name Research Code Research Phase Company Indications Clinical Trials
Hu-7691 Hu-7691 Phase 1 Clinical Zhejiang University Neoplasms Details
Oxysterols (Intsel Chimos) Clinical Centre National De La Recherche Scientifique (Cnrs) Glioma Details
NTQ-1062 NTQ1062; NTQ-1062 Phase 1 Clinical Nanjing Zhengda Tianqing Pharmaceutical Co Ltd Solid tumours Details
MSC-2363318A M-2698; MSC-2363318A Merck Serono Details
BAY-1125976 BAY-1125976 Bayer AG Details
TAS-117 TAS-117 Phase 2 Clinical Otsuka Pharmaceutical Co Ltd, Taiho Pharmaceutical Co Ltd Solid tumours Details
HZB-0071 HZB-0071 Phase 1 Clinical Wuxi Apptec Co Ltd, Heilongjiang Zbd Pharmaceutical Co Ltd Neoplasms Details
Honokiol HU-002; JRF-101 Phase 1 Clinical Anacor Pharmaceuticals Inc Non-alcoholic Fatty Liver Disease; Gingival Diseases; Carcinoma, Non-Small-Cell Lung Details
Triciribine Phosphate NSC-154020; PTX-002; API-2; TCN-P; VQD-002-ORAL; VQD-002; NSC-280594; PTX-200 Phase 2 Clinical National Cancer Institute Ovarian Neoplasms; Hematologic Neoplasms; Leukemia; Neoplasms; Breast Neoplasms Details
Selumetinib sulfate/MK-2206 Phase 2 Clinical Astrazeneca Plc, Merck & Co Inc Rectal Neoplasms; Triple Negative Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lung Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung Details
Uprosertib/Trametinib Dimethyl Sulfoxide Phase 2 Clinical Novartis Pharma Ag Leukemia, Myeloid, Acute; Endometrial Neoplasms; Uterine Cervical Neoplasms Details
Miransertib MK-7075; ARQ-092 Phase 2 Clinical Arqule Inc Ovarian Neoplasms; Solid tumours; Proteus Infections; Neoplasms; Proteus Syndrome; Lymphoma; Endometrial Neoplasms Details
Capivasertib AZD-5363 Phase 3 Clinical Astrazeneca Pharmaceutical Co Ltd Glioma; Prostatic Neoplasms; Cholangiocarcinoma; Colorectal Neoplasms; Peritoneal Neoplasms; Thyroid Neoplasms; Endometrial Neoplasms; Lung Neoplasms; Esophageal adenocarcinoma; Lymphoma; Breast Neoplasms; Fallopian Tube Neoplasms; Uterine Neoplasms; Lymphoma, Non-Hodgkin; Metastatic breast cancer; Carcinoma, Squamous Cell; Uterine Cervical Neoplasms; Melanoma; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Triple Negative Breast Neoplasms; Solid tumours; Liver Neoplasms; Ovarian Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Renal Cell; Neoplasms; Hematologic Neoplasms; Pancreatic Neoplasms; Colonic Neoplasms; Skin Neoplasms; Carcinoma, Ovarian Epithelial; Carcinoma, Transitional Cell; Urinary Bladder Neoplasms; Multiple Myeloma; Prostatic Neoplasms, Castration-Resistant Details
RX-0301 RX-0301; WGI-0301; RX-0201改良型; RX-0201 nanoliposomal; RX-0201 Nano; RX-0201-N Phase 1 Clinical Rexahn Pharmaceuticals Inc Liver Neoplasms; Solid tumours; Neoplasms Details
Afuresertib ASB-183; GSK-2110183; GSK-2110183B; GSK-2110183C; GSK-21110183; LAE-002 Phase 3 Clinical Glaxosmithkline Plc, Novartis Pharma Ag Histiocytosis, Langerhans-Cell; Uterine Cervical Neoplasms; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Leukemia, Lymphocytic, Chronic, B-Cell; Endometrial Neoplasms; Fallopian Tube Neoplasms; Metastatic breast cancer; Peritoneal Neoplasms; Solid tumours; Breast Neoplasms; Multiple Myeloma; Neoplasms; Triple Negative Breast Neoplasms; Stomach Neoplasms; Esophageal Neoplasms; Hematologic Neoplasms; Ovarian Neoplasms Details
Ipatasertib Dihydrochloride RG-7440; GCD-0068; GDC-0068; RO-5532961 Phase 3 Clinical Array Biopharma, F. Hoffmann-La Roche Ltd Hepatic Insufficiency; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Carcinoma, Endometrioid; Lymphoma, Non-Hodgkin; Fallopian Tube Neoplasms; Neoplasms, Unknown Primary; Endometrial Neoplasms; Carcinoma, Squamous Cell; Uterine Neoplasms; Paranasal Sinus Diseases; Paranasal Sinus Neoplasms; Laryngeal Neoplasms; Mouth Neoplasms; Peritoneal Neoplasms; Ovarian Neoplasms; Oropharyngeal Neoplasms; Prostatic Neoplasms; Cholangiocarcinoma; Breast Neoplasms; Prostatic Neoplasms, Castration-Resistant; Glioblastoma; Hypopharyngeal Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Cystadenocarcinoma, Serous; Stomach Neoplasms; Squamous Cell Carcinoma of Head and Neck; Neoplasm, Residual; Head and Neck Neoplasms; Solid tumours Details
MK-2206 MK2206; MK-2206; BIND-2206; NSC-749607 Phase 2 Clinical Merck Sharp & Dohme Corp Peritoneal Neoplasms; Waldenstrom Macroglobulinemia; Neoplasms, Gonadal Tissue; Carcinoma, Squamous Cell; Glioma; Lymphoma, T-Cell, Cutaneous; Lymphoma, Large-Cell, Anaplastic; Lymphoma, T-Cell; Thymoma; Gallbladder Neoplasms; Carcinoma, Pancreatic Ductal; Leukemia, Myeloid, Acute; Adenocarcinoma, Bronchiolo-Alveolar; Sezary Syndrome; Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative; Lymphoproliferative Disorders; Leukemia, Myeloid, Chronic-Phase; Colorectal Neoplasms; Bile Duct Neoplasms; Nasopharyngeal Carcinoma; Carcinoma, Adenosquamous; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Monocytic, Acute; Breast Neoplasms, Male; Mycosis Fungoides; Carcinoma, Hepatocellular; Leukemia, T-Cell; Leukemia, Large Granular Lymphocytic; Leukemia, Prolymphocytic; Leukemia, Lymphocytic, Chronic, B-Cell; Melanoma; Carcinoma, Non-Small-Cell Lung; Adenocarcinoma; Lymphoma, Follicular; Lymphoma; Leukemia, Myelomonocytic, Juvenile; Adenocarcinoma, Mucinous; Burkitt Lymphoma; Lymphoma, Non-Hodgkin; Intraocula Details
Iopofosine I-131 HOT; CLR1404 I-131; I-131-CLR1404; (131)I-NM 404; 131I-NM-404; CLR-131; (131)I-CLR1404; NM404 Phase 2 Clinical University Of Michigan Sarcoma, Ewing; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma; Glioma; Waldenstrom Macroglobulinemia; Diffuse Intrinsic Pontine Glioma; Neuroblastoma; Lymphoma, Mantle-Cell; Osteosarcoma; Head and Neck Neoplasms; Brain Neoplasms; Multiple Myeloma; Central Nervous System Neoplasms; Lymphoma, Large B-Cell, Diffuse; Neoplasms; Rhabdomyosarcoma; Lymphoma, B-Cell, Marginal Zone; Solid tumours Details
Uprosertib GSK-795; GSK-2141795; GSK-2141795C; UPB-795 Phase 2 Clinical Glaxosmithkline Plc, Novartis Pharma Ag, National Cancer Institute Solid tumours; Hematologic Neoplasms; Neoplasms; Triple Negative Breast Neoplasms; Multiple Myeloma; Breast Neoplasms; Lymphoma; Endometrial Neoplasms; Uterine Neoplasms; Leukemia, Myeloid, Acute; Melanoma; Uterine Cervical Neoplasms; Adenocarcinoma Details
TIC-10 ONC201 - Oncoceutics; ONC201/TIC10; NSC-350625; TIC-10; ONC-201 Phase 3 Clinical Oncoceutics Inc Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Adenomatous Polyps; Endometrial Neoplasms; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Glioma; Colorectal Neoplasms; Gliosarcoma; Diffuse Intrinsic Pontine Glioma; Solid tumours; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Mantle-Cell; Multiple Myeloma; Central Nervous System Neoplasms; Thalamic Diseases; Myelodysplastic Syndromes; Triple Negative Breast Neoplasms; Glioblastoma; Adenomatous Polyposis Coli Details

This web search service is supported by Google Inc.

totop